Skip to main content
Clinical Trials/JPRN-UMIN000036788
JPRN-UMIN000036788
Completed
N/A

An investigation of therapeutic efficacy when switching from intensive insulin therapy to long-acting insulin plus either dulaglutide or empagliflozin in type 2 diabetes patients - An investigation of therapeutic efficacy when switching from intensive insulin therapy to long-acting insulin plus either dulaglutide or empagliflozin in type 2 diabetes patients

Chigasaki Municipal Hospital0 sites60 target enrollmentMay 18, 2019
Conditionstype 2 diabetes

Overview

Phase
N/A
Intervention
Not specified
Conditions
type 2 diabetes
Sponsor
Chigasaki Municipal Hospital
Enrollment
60
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 18, 2019
End Date
November 29, 2021
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\. Patients with serious hepatic dysfunction 2\. Patients with serious renal dysfunction 3\. Patients taking steroids 4\. Patients with cancer 5\. Patients with severe infection or serious injury 6\. Patients who are or could be pregnant 7\. Patients with an allergy to the drug to be used or for whom it is contraindicated 8\. Any other patients considered by the investigator or a subinvestigator to be unsuitable to participate in the study

Outcomes

Primary Outcomes

Not specified

Similar Trials